Sharps technology announces pricing of $3.8 million private placement priced at the market

Proceeds to support the manufacturing of pre-filled specialty syringe systems through its partnership with nephron pharmaceuticals proceeds to support the manufacturing of pre-filled specialty syringe systems through its partnership with nephron pharmaceuticals
STSS Ratings Summary
STSS Quant Ranking